CD4 and breast neoplasm: Immunophenotyping the CD45RO-expressing lymphocytes infiltrating breast tumor tissues revealed that the majority of CD45RO+ lymphocytes displayed the CD3 pan T-cells marker (more than 90%), followed by CD8+, CD4+, and CD16+/CD56+ NK cells.